Matthew Gdovin, an associate professor in the UTSA Department of Biology, has developed a newly patented method to kill cancer cells. His discovery, described in research published in The Journal of Clinical Oncology, may tremendously help people with inoperable or hard-to-reach tumors, as well as young children stricken with cancer.
Gdovin’s top-tier research involves injecting a chemical compound, nitrobenzaldehyde, into the tumor and allowing it to diffuse into the tissue. He then aims a beam of light at the tissue, causing the cells to become very acidic inside and, essentially, commit suicide. Within two hours, Gdovin estimates up to 95 percent of the targeted cancer cells are dead.
“Even though there are many different types of cancers, the one thing they have in common is their susceptibility to this induced cell suicide,” he said.
Gdovin tested his method against triple negative breast cancer, one of the most aggressive types of cancer and one of the hardest to treat. The prognosis for triple negative breast cancer is usually very poor. After one treatment in the laboratory, he was able to stop the tumor from growing and double chances of survival in mice.
“All forms of cancer attempt to make cells acidic on the outside as a way to attract the attention of a blood vessel, which attempts to get rid of the acid,” he said. “Instead, the cancer latches onto the blood vessel and uses it to make the tumor larger and larger.”
Chemotherapy treatments target all cells in the body, and certain chemotherapeutics try to keep cancer cells acidic as a way to kill the cancer. This is what causes many cancer patients to lose their hair and become sickly. Gdovin’s method, however, is more precise and can target just the tumor.
In the past two years, he’s developed his photodynamic cancer therapy to the point where it’s non-invasive. It now requires just an injection of the nitrobenzaldehyde fluid followed by a flash of an ultraviolet light to cause the cancer-killing reaction. Gdovin has now begun to test the method on drug-resistant cancer cells to make his therapy as strong as possible. He’s also started to develop a nanoparticle that can be injected into the body to target metastasized cancer cells. The nanoparticle is activated with a wavelength of light that it can pass harmlessly through skin, flesh and bone and still activate the the cancer-killing nanoparticle.
Gdovin hopes that his non-invasive method will help cancer patients with tumors in areas that have proven problematic for surgeons, such as the brain stem, aorta or spine. It could also help people who have received the maximum amount of radiation treatment and can no longer cope with the scarring and pain that goes along with it, or children who are at risk of developing mutations from radiation as they grow older.
“There are so many types of cancer for which the prognosis is very poor,” he said. “We’re thinking outside the box and finding a way to do what for many people is simply impossible.”
Learn more: UTSA researcher develops new, non-invasive method to wipe out cancerous tumors
The Latest on: Photodynamic cancer therapy
[google_news title=”” keyword=”Photodynamic cancer therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Photodynamic cancer therapy
- Red light therapy could help prevent skin canceron April 25, 2024 at 3:24 pm
Known on the internet for its cosmetic benefits, a South Florida doctor says red light therapy helped her beat and recover from skin cancer.
- ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferenceson April 24, 2024 at 7:00 am
Preliminary results from Phase 3 ENLIGHTED study in low grade upper tract urothelial cancer (UTUC) to be presented at AUA and ASCO Trial design for Phase 1 study of Padeliporfin VTP in pancreatic ...
- Photodynamic Therapy Market Overviewon April 18, 2024 at 5:00 pm
The Photodynamic Therapy (PDT) Market offers a non-invasive treatment modality for various medical conditions, including cancer, dermatological disorders, and ophthalmic diseases. Utilizing ...
- Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Studyon April 18, 2024 at 1:22 pm
In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
- Turning microalgae into light-controlled, soft bio-microrobotson April 3, 2024 at 5:00 pm
the Ebot can be induced to perform precise photodynamic therapy on cancer cells in target areas. This light-controlled soft microrobot provides a new bio-microrobotic tool that can execute ...
- New synthesis platform allows for rapid cancer drug synthesis and testingon March 31, 2024 at 5:00 pm
"For an agent to be effective for photodynamic therapy, it should be completely ... and its efficiency when killing cancer cells exposed to light. They then used the information to design a ...
- My Experience Using Lasers for Skin Lesionson February 16, 2024 at 1:13 pm
If you have sun damage, such as actinic keratoses or nonmelanoma skin cancer (basal cell or squamous), you might ask your dermatologist about photodynamic therapy. The unpleasantness of the ...
- Ovarian Cancer Resource Centeron April 27, 2023 at 4:12 am
Ovarian cancer starts in one or both ovaries, or in the fallopian tubes, or in the abdominal lining called the peritoneum. Women between the ages of 55 and 63 are most likely to get ovarian cancer.
- Experts Employ Nanomaterial-Based Phototherapy Modalities for Cancer Treatmenton March 15, 2022 at 5:00 pm
Photodynamic therapy (PDT) is another technique that uses laser light ... To be effective, PDT requires ambient oxygen to produce sufficient ROS to destroy tumor cells. In cancer therapies using this ...
- Treatment for Squamous Cell Carcinomaon July 4, 2016 at 5:27 pm
Our skin cancer experts are experienced in helping people make ... For people with this precancerous condition, we offer photodynamic therapy. The procedure involves applying a special chemical to the ...
via Bing News